a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1927 clinical trials
A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

The main purpose of this study is to evaluate the safety and tolerability of LY3372993 in participants with AD. The study will also investigate how much LY3372993 gets into the bloodstream and will test the effects of LY3372993. Participation could last up to about 54 weeks and may include up …

alzheimer's disease
cognitive impairment
mini-mental state examination
mental state examination
dementia
  • 0 views
  • 19 Feb, 2024
  • 7 locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

ki-ras
kras
solid tumor
metastatic malignant solid tumor
solid tumour
  • 0 views
  • 19 Feb, 2024
  • 8 locations
Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC

The aim of the single-arm, open-label, phase II clinical trial is to assess efficacy and safety of lenvatinib as a preoperative conversion therapy in patients with potentially resectable HCC. Investigator hypothesized that lenvatinib may be an effective conversion treatment for HCC, and preoperative treatment with lenvatinib can improve resectability in …

  • 0 views
  • 19 Feb, 2024
  • 4 locations
Study to Evaluate the Effect of a Probiotic in COVID-19

A prospective case-control pilot study to evaluate the possible effect of a probiotic mixture in the improvement of symptoms, the reduction in the number of days of hospitalization and the increase in the percentage of patients with negative PCR after infection with the coronavirus SARS-CoV-2.

covid-19
coronavirus infection
SARS
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension

This study is designed to investigate whether sympathoinhibition with moxonidine could provide added metabolic benefit compared to the second line therapy in the current guidelines.

hypertension
amlodipine
amlodipine 5 mg
ace inhibitor
moxonidine
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)

In this study, subjects will be randomly assigned to the following two groups according to a 1:1 ratio: (A) Standard maintenance programme group, pembrolizumab 200mg, every 3 weeks, for a total of 2 years of follow-up and follow-up for 1 year; (B) Improvement maintenance programme group, pembrolizumab 200mg, every 6 …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients

            The goal of this research study is to test how good an app is in making asthma easier to manage for 372 adolescents/young adults. The app is a mobile version of the asthma action plan. mAAP

Accepts healthy volunteers
  • 8 views
  • 20 Sep, 2024
  • 1 location
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies

The study will consist of a dose-escalation stage and an expansion stage where participants will be enrolled into indication-specific cohorts.

cyclophosphamide
fludarabine
b-cell lymphoma refractory
rituximab
lymphoma
  • 0 views
  • 19 Feb, 2024
  • 3 locations
Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA)

The main objective is to determine the effectiveness of a program which consists of multidisciplinary, intensive and individualized interventions, carried out by a group of health professionals (psychiatrist, psychologist, mental health nurse, primary care doctors, pharmacist), during six-month, to improve the global cardiovascular risk (CVR) in patients with schizophrenia.

hypertension
intervention program
hyperglycemia
schizophrenia
hypercholesterolemia
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

The purpose of this study is to find out whether enasidenib is a safe and effective treatment for CCUS.

  • 0 views
  • 02 Dec, 2024
  • 7 locations